Posts Tagged ‘Medicine’
-
Thursday, January 19th, 2012 at 09:27 | Comments Off
How Often Should Women Be Screened for Osteoporosis?Categories: Wall Street Journal, aging
The U.S. Preventive Services Task Force recommends women aged 65 and up be screened for osteoporosis, without saying exactly how often that should happen.
But new research offers some guidance, suggesting that women with a good bone density score may be able to wait 15 years before their next screening because they are unlikely to develop osteoporosis before then. A poor score, however, might suggest a test the next year.
The goal of screening is to diagnose a woman when she has ..read more
-
Friday, January 13th, 2012 at 00:36 | Comments Off
A.M. Vitals: Coca-Cola Found Fungicide in OJ From BrazilCategories: Wall Street Journal
Orange Juice Worries: Coca-Cola said it found an unapproved fungicide in some of it and its competitors’ orange juice imported from Brazil, though it wouldn’t identify the brands, the WSJ reports. Coke makes Simply Orange and Minute Maid. The FDA is testing OJ from supermarket shelves for the fungicide, but the EPA said consumption of juice that includes fungicide at the levels that have been reported doesn’t ..read more
-
Friday, January 6th, 2012 at 07:52 | Comments Off
A Gunshot Wound to the Abdomen No Longer Means Automatic SurgeryCategories: Wall Street Journal
On TV crime shows, when people who have been stabbed or shot in the abdomen get to the hospital they’re inevitably rushed into surgery. (Which is why Lennie Briscoe often had to wait for witness statements until after the operation.)
In real life, though, that’s happening less frequently. Certain patients can avoid emergency exploratory surgery of the abdomen — even some who still have bullets lodged inside them — explains Adil Haider, an associate professor of surgery, anesthesiology and critical care ..read more
-
Friday, December 16th, 2011 at 04:41 | Comments Off
IOM Says Chimpanzees Aren’t Necessary For Most Medical ResearchCategories: Wall Street Journal
Are chimpanzees necessary for medical research?
A report from the Institute of Medicine out today answers that question with a very qualified “yes,” saying that most biomedical experiments don’t require the use of chimps and that given the genetic ties and physical traits the animals share with humans, the NIH should fund such research only in certain specific circumstances.
The recommendations, which apply to research funded or supported by the NIH, include three criteria for the use of chimps in biomedical ..read more
-
Thursday, December 8th, 2011 at 07:28 | Comments Off
IOM Report Has Familiar List of Known Breast Cancer RisksCategories: Wall Street Journal
The environmental risk factors for breast cancer supported by “consistent scientific evidence,” according to a new report by the Institute of Medicine and commissioned by Susan G. Komen for the Cure, will sound pretty familiar to anyone who has been paying attention to breast-cancer prevention.
In that corner: unnecessary medical radiation, combination hormone therapy for menopause, excess alcohol consumption, being overweight, lack of exercise and tobacco use.
Not to worry about, according to the report: hair dye for personal use and non-ionizing ..read more
-
Saturday, November 19th, 2011 at 05:13 | Comments Off
What Does the FDA’s Avastin Decision Mean for Breast Cancer Patients?Categories: Wall Street Journal
The Food and Drug Administration’s decision to revoke approval of Roche’s Avastin for advanced breast cancer is likely to curtail use of the $6 billion-a-year drug for such patients. But it’s not likely to put an end to prescribing.
Today’s action doesn’t affect the drug’s other approved uses, which include certain types of colon, lung, kidney and brain cancers, the FDA said. And physicians are free to prescribe an approved drug for any use they see fit.
One question, ..read more
-
Thursday, November 10th, 2011 at 04:32 | Comments Off
IOM Recommends Independent Safety Agency For Health ITCategories: Wall Street Journal
The federal government is spending billions to encourage hospitals and doctors to use electronic medical records.
But a report out yesterday from the Institute of Medicine finds that digitized records and other health IT products are expected to improve patient safety — but only when the products are well-designed and correctly used.
“Designed and applied inappropriately, health IT can add an additional layer of complexity to the already complex delivery of health care, which can lead to unintended adverse consequences, for example ..read more
-
Thursday, October 27th, 2011 at 03:15 | Comments Off
Flu Shot Could Be Better, But For Now It’s The Best We’ve GotCategories: Wall Street Journal
When you roll up your sleeve for an annual flu shot, have you ever stopped to consider how well vaccination against the disease actually works?
The answer, according to a review of previous research published in the Lancet Infectious Diseases, is pretty well – but with plenty of room for improvement. Researchers found the flu vaccine “can provide moderate protection” against the flu, “but such protection is greatly reduced or absent in some seasons.”
Evidence for protection in people with medical complications ..read more
-
Monday, October 24th, 2011 at 23:41 | Comments Off
Informed Patient: Advance Directives Cut Unwanted HospitalizationsCategories: Wall Street Journal
Frail elderly patients who have advance directives through a program to communicate treatment preferences have fewer unwanted hospitalizations, according to a new study published online in the Journal of the American Geriatrics Society.
The program uses a form known as POLST — Physician Orders for Life-Sustaining Treatment — which allows patients to document their preferences about certain treatments. Signed by both patient and doctor, the form spells out choices including whether a patient wants to be on a breathing machine or ..read more
-
Friday, October 21st, 2011 at 05:09 | Comments Off
Not Just a Cheerleader: Foundation Helped Drive Cystic-Fibrosis ResearchCategories: Wall Street Journal
A young patient holds her experimental cystic fibrosis medication, Vertex’s Kalydeco.
The WSJ reports today on the two-decade quest to develop drugs for cystic fibrosis following the discovery of the gene responsible for the respiratory disease.
In addition to the scientific hurdles, a big challenge facing those seeking treatments was finding a company willing to make the investment. “Very few returned my call,” recalls Robert Beall, chief executive of the Cystic Fibrosis Foundation.
The foundation ended up taking a role normally reserved for ..read more
